JP2015208495A - 遊技台 - Google Patents
遊技台 Download PDFInfo
- Publication number
- JP2015208495A JP2015208495A JP2014092082A JP2014092082A JP2015208495A JP 2015208495 A JP2015208495 A JP 2015208495A JP 2014092082 A JP2014092082 A JP 2014092082A JP 2014092082 A JP2014092082 A JP 2014092082A JP 2015208495 A JP2015208495 A JP 2015208495A
- Authority
- JP
- Japan
- Prior art keywords
- shows
- launch
- special
- pachinko machine
- game
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000008859 change Effects 0.000 claims abstract description 264
- 238000010304 firing Methods 0.000 claims description 882
- 238000000034 method Methods 0.000 description 1280
- 230000008569 process Effects 0.000 description 1256
- 230000000694 effects Effects 0.000 description 661
- 238000003860 storage Methods 0.000 description 444
- 238000001514 detection method Methods 0.000 description 416
- 238000012545 processing Methods 0.000 description 364
- 230000006854 communication Effects 0.000 description 343
- 238000004891 communication Methods 0.000 description 341
- 230000005540 biological transmission Effects 0.000 description 308
- 238000003825 pressing Methods 0.000 description 237
- 238000010586 diagram Methods 0.000 description 226
- 238000005034 decoration Methods 0.000 description 203
- 238000012790 confirmation Methods 0.000 description 197
- 238000012986 modification Methods 0.000 description 151
- 230000004048 modification Effects 0.000 description 151
- 238000004519 manufacturing process Methods 0.000 description 138
- 238000004458 analytical method Methods 0.000 description 102
- 230000005856 abnormality Effects 0.000 description 85
- 230000006870 function Effects 0.000 description 69
- 230000033001 locomotion Effects 0.000 description 66
- 238000002834 transmittance Methods 0.000 description 66
- 238000012544 monitoring process Methods 0.000 description 57
- KRQUFUKTQHISJB-YYADALCUSA-N 2-[(E)-N-[2-(4-chlorophenoxy)propoxy]-C-propylcarbonimidoyl]-3-hydroxy-5-(thian-3-yl)cyclohex-2-en-1-one Chemical compound CCC\C(=N/OCC(C)OC1=CC=C(Cl)C=C1)C1=C(O)CC(CC1=O)C1CCCSC1 KRQUFUKTQHISJB-YYADALCUSA-N 0.000 description 54
- 210000003811 finger Anatomy 0.000 description 54
- 238000013461 design Methods 0.000 description 51
- 238000011084 recovery Methods 0.000 description 48
- 239000004973 liquid crystal related substance Substances 0.000 description 44
- 230000001965 increasing effect Effects 0.000 description 41
- 238000005096 rolling process Methods 0.000 description 41
- 230000004913 activation Effects 0.000 description 39
- 238000001994 activation Methods 0.000 description 39
- 230000001276 controlling effect Effects 0.000 description 38
- 230000009467 reduction Effects 0.000 description 35
- 230000001976 improved effect Effects 0.000 description 31
- 230000002829 reductive effect Effects 0.000 description 31
- 230000007704 transition Effects 0.000 description 30
- 238000005286 illumination Methods 0.000 description 25
- 239000000758 substrate Substances 0.000 description 23
- 239000011521 glass Substances 0.000 description 20
- 238000012546 transfer Methods 0.000 description 20
- 239000011347 resin Substances 0.000 description 19
- 229920005989 resin Polymers 0.000 description 19
- 238000006243 chemical reaction Methods 0.000 description 16
- 230000007423 decrease Effects 0.000 description 16
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical group [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 15
- 210000003813 thumb Anatomy 0.000 description 15
- 239000003990 capacitor Substances 0.000 description 14
- 239000013078 crystal Substances 0.000 description 14
- 230000007246 mechanism Effects 0.000 description 13
- 230000003111 delayed effect Effects 0.000 description 12
- 230000002265 prevention Effects 0.000 description 12
- 230000002159 abnormal effect Effects 0.000 description 11
- 210000000245 forearm Anatomy 0.000 description 11
- 238000009877 rendering Methods 0.000 description 11
- 238000007667 floating Methods 0.000 description 9
- 230000004044 response Effects 0.000 description 9
- 230000000630 rising effect Effects 0.000 description 9
- 230000001960 triggered effect Effects 0.000 description 9
- 102100035475 Blood vessel epicardial substance Human genes 0.000 description 8
- 101001094636 Homo sapiens Blood vessel epicardial substance Proteins 0.000 description 8
- 101000608194 Homo sapiens Pyrin domain-containing protein 1 Proteins 0.000 description 8
- 101000595404 Homo sapiens Ribonucleases P/MRP protein subunit POP1 Proteins 0.000 description 8
- 230000009471 action Effects 0.000 description 8
- 230000008901 benefit Effects 0.000 description 8
- 230000029087 digestion Effects 0.000 description 8
- 230000000007 visual effect Effects 0.000 description 8
- YLZOPXRUQYQQID-UHFFFAOYSA-N 3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]propan-1-one Chemical compound N1N=NC=2CN(CCC=21)CCC(=O)N1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F YLZOPXRUQYQQID-UHFFFAOYSA-N 0.000 description 7
- 238000004364 calculation method Methods 0.000 description 7
- 230000001186 cumulative effect Effects 0.000 description 7
- 238000007599 discharging Methods 0.000 description 7
- 230000012447 hatching Effects 0.000 description 7
- 230000015654 memory Effects 0.000 description 7
- 230000036961 partial effect Effects 0.000 description 7
- 230000002093 peripheral effect Effects 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 230000000717 retained effect Effects 0.000 description 7
- 238000009434 installation Methods 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- HMUNWXXNJPVALC-UHFFFAOYSA-N 1-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C(CN1CC2=C(CC1)NN=N2)=O HMUNWXXNJPVALC-UHFFFAOYSA-N 0.000 description 5
- 230000002238 attenuated effect Effects 0.000 description 5
- 239000012141 concentrate Substances 0.000 description 5
- 230000008094 contradictory effect Effects 0.000 description 5
- 230000003247 decreasing effect Effects 0.000 description 5
- 239000000428 dust Substances 0.000 description 5
- 239000012466 permeate Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 210000000707 wrist Anatomy 0.000 description 5
- LDXJRKWFNNFDSA-UHFFFAOYSA-N 2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound C1CN(CC2=NNN=C21)CC(=O)N3CCN(CC3)C4=CN=C(N=C4)NCC5=CC(=CC=C5)OC(F)(F)F LDXJRKWFNNFDSA-UHFFFAOYSA-N 0.000 description 4
- 101000929940 Homo sapiens Adrenocortical dysplasia protein homolog Proteins 0.000 description 4
- 101000730577 Homo sapiens p21-activated protein kinase-interacting protein 1 Proteins 0.000 description 4
- 208000025174 PANDAS Diseases 0.000 description 4
- 208000021155 Paediatric autoimmune neuropsychiatric disorders associated with streptococcal infection Diseases 0.000 description 4
- 240000004718 Panda Species 0.000 description 4
- 235000016496 Panda oleosa Nutrition 0.000 description 4
- 241000722921 Tulipa gesneriana Species 0.000 description 4
- 230000003321 amplification Effects 0.000 description 4
- 238000003780 insertion Methods 0.000 description 4
- 230000037431 insertion Effects 0.000 description 4
- 238000003199 nucleic acid amplification method Methods 0.000 description 4
- 102100032579 p21-activated protein kinase-interacting protein 1 Human genes 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 230000005855 radiation Effects 0.000 description 4
- 230000035807 sensation Effects 0.000 description 4
- 238000004904 shortening Methods 0.000 description 4
- 210000004243 sweat Anatomy 0.000 description 4
- OHVLMTFVQDZYHP-UHFFFAOYSA-N 1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-2-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound N1N=NC=2CN(CCC=21)C(CN1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)=O OHVLMTFVQDZYHP-UHFFFAOYSA-N 0.000 description 3
- YIWGJFPJRAEKMK-UHFFFAOYSA-N 1-(2H-benzotriazol-5-yl)-3-methyl-8-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carbonyl]-1,3,8-triazaspiro[4.5]decane-2,4-dione Chemical compound CN1C(=O)N(c2ccc3n[nH]nc3c2)C2(CCN(CC2)C(=O)c2cnc(NCc3cccc(OC(F)(F)F)c3)nc2)C1=O YIWGJFPJRAEKMK-UHFFFAOYSA-N 0.000 description 3
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 3
- WZFUQSJFWNHZHM-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)N1CC2=C(CC1)NN=N2 WZFUQSJFWNHZHM-UHFFFAOYSA-N 0.000 description 3
- JAWMENYCRQKKJY-UHFFFAOYSA-N [3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-ylmethyl)-1-oxa-2,8-diazaspiro[4.5]dec-2-en-8-yl]-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]methanone Chemical compound N1N=NC=2CN(CCC=21)CC1=NOC2(C1)CCN(CC2)C(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F JAWMENYCRQKKJY-UHFFFAOYSA-N 0.000 description 3
- 230000004397 blinking Effects 0.000 description 3
- 230000008602 contraction Effects 0.000 description 3
- 230000006866 deterioration Effects 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 238000005401 electroluminescence Methods 0.000 description 3
- 230000008921 facial expression Effects 0.000 description 3
- 210000003128 head Anatomy 0.000 description 3
- 230000009191 jumping Effects 0.000 description 3
- 238000011068 loading method Methods 0.000 description 3
- 230000005389 magnetism Effects 0.000 description 3
- 230000007257 malfunction Effects 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 230000008450 motivation Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 230000002441 reversible effect Effects 0.000 description 3
- 238000009987 spinning Methods 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- JQMFQLVAJGZSQS-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-N-(2-oxo-3H-1,3-benzoxazol-6-yl)acetamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)NC1=CC2=C(NC(O2)=O)C=C1 JQMFQLVAJGZSQS-UHFFFAOYSA-N 0.000 description 2
- CONKBQPVFMXDOV-QHCPKHFHSA-N 6-[(5S)-5-[[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]methyl]-2-oxo-1,3-oxazolidin-3-yl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C[C@H]1CN(C(O1)=O)C1=CC2=C(NC(O2)=O)C=C1 CONKBQPVFMXDOV-QHCPKHFHSA-N 0.000 description 2
- 241001539473 Euphoria Species 0.000 description 2
- 206010015535 Euphoric mood Diseases 0.000 description 2
- 125000002066 L-histidyl group Chemical group [H]N1C([H])=NC(C([H])([H])[C@](C(=O)[*])([H])N([H])[H])=C1[H] 0.000 description 2
- MKYBYDHXWVHEJW-UHFFFAOYSA-N N-[1-oxo-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propan-2-yl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(C(C)NC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 MKYBYDHXWVHEJW-UHFFFAOYSA-N 0.000 description 2
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 2
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 2
- 230000004308 accommodation Effects 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- 230000009194 climbing Effects 0.000 description 2
- 230000001143 conditioned effect Effects 0.000 description 2
- 230000000994 depressogenic effect Effects 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 230000003760 hair shine Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000000873 masking effect Effects 0.000 description 2
- NJPPVKZQTLUDBO-UHFFFAOYSA-N novaluron Chemical compound C1=C(Cl)C(OC(F)(F)C(OC(F)(F)F)F)=CC=C1NC(=O)NC(=O)C1=C(F)C=CC=C1F NJPPVKZQTLUDBO-UHFFFAOYSA-N 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000008093 supporting effect Effects 0.000 description 2
- 239000004925 Acrylic resin Substances 0.000 description 1
- 229920000178 Acrylic resin Polymers 0.000 description 1
- 101100400452 Caenorhabditis elegans map-2 gene Proteins 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 101001071145 Homo sapiens Polyhomeotic-like protein 1 Proteins 0.000 description 1
- 101000711475 Homo sapiens Serpin B10 Proteins 0.000 description 1
- 101000868880 Homo sapiens Serpin B13 Proteins 0.000 description 1
- 101000701902 Homo sapiens Serpin B4 Proteins 0.000 description 1
- 102100037591 Neuroserpin Human genes 0.000 description 1
- 102100033222 Polyhomeotic-like protein 1 Human genes 0.000 description 1
- 102100034012 Serpin B10 Human genes 0.000 description 1
- 102100032322 Serpin B13 Human genes 0.000 description 1
- 102100030326 Serpin B4 Human genes 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 101000959880 Solanum tuberosum Aspartic protease inhibitor 4 Proteins 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 230000007175 bidirectional communication Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000000881 depressing effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 230000005279 excitation period Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 238000009432 framing Methods 0.000 description 1
- 230000017525 heat dissipation Effects 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 108010080874 neuroserpin Proteins 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- NHDHVHZZCFYRSB-UHFFFAOYSA-N pyriproxyfen Chemical compound C=1C=CC=NC=1OC(C)COC(C=C1)=CC=C1OC1=CC=CC=C1 NHDHVHZZCFYRSB-UHFFFAOYSA-N 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 229910000859 α-Fe Inorganic materials 0.000 description 1
Landscapes
- Pinball Game Machines (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2014092082A JP2015208495A (ja) | 2014-04-25 | 2014-04-25 | 遊技台 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2014092082A JP2015208495A (ja) | 2014-04-25 | 2014-04-25 | 遊技台 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017234899A Division JP6402339B2 (ja) | 2017-12-07 | 2017-12-07 | 遊技台 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2015208495A true JP2015208495A (ja) | 2015-11-24 |
JP2015208495A5 JP2015208495A5 (enrdf_load_stackoverflow) | 2016-09-15 |
Family
ID=54611222
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2014092082A Pending JP2015208495A (ja) | 2014-04-25 | 2014-04-25 | 遊技台 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2015208495A (enrdf_load_stackoverflow) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2017099715A (ja) * | 2015-12-02 | 2017-06-08 | 株式会社大一商会 | 遊技機 |
JP2017099716A (ja) * | 2015-12-02 | 2017-06-08 | 株式会社大一商会 | 遊技機 |
JP2018023885A (ja) * | 2017-11-16 | 2018-02-15 | 株式会社サンセイアールアンドディ | 遊技機 |
JP2018108216A (ja) * | 2016-12-28 | 2018-07-12 | 株式会社大一商会 | 遊技機 |
JP2018118106A (ja) * | 2018-03-29 | 2018-08-02 | 株式会社サンセイアールアンドディ | 遊技機 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010172370A (ja) * | 2009-01-27 | 2010-08-12 | Kyoraku Sangyo Kk | 遊技機 |
JP2013039311A (ja) * | 2011-08-19 | 2013-02-28 | Sankyo Co Ltd | 遊技機 |
-
2014
- 2014-04-25 JP JP2014092082A patent/JP2015208495A/ja active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010172370A (ja) * | 2009-01-27 | 2010-08-12 | Kyoraku Sangyo Kk | 遊技機 |
JP2013039311A (ja) * | 2011-08-19 | 2013-02-28 | Sankyo Co Ltd | 遊技機 |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2017099715A (ja) * | 2015-12-02 | 2017-06-08 | 株式会社大一商会 | 遊技機 |
JP2017099716A (ja) * | 2015-12-02 | 2017-06-08 | 株式会社大一商会 | 遊技機 |
JP2018108216A (ja) * | 2016-12-28 | 2018-07-12 | 株式会社大一商会 | 遊技機 |
JP2018023885A (ja) * | 2017-11-16 | 2018-02-15 | 株式会社サンセイアールアンドディ | 遊技機 |
JP2018118106A (ja) * | 2018-03-29 | 2018-08-02 | 株式会社サンセイアールアンドディ | 遊技機 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6277452B2 (ja) | 遊技台 | |
JP6158724B2 (ja) | 遊技台 | |
JP2015208497A (ja) | 遊技台 | |
JP6155485B2 (ja) | 遊技台 | |
JP6603912B2 (ja) | 遊技台 | |
JP2015071003A (ja) | 遊技台 | |
JP2017047052A (ja) | 遊技台 | |
JP5935936B1 (ja) | 遊技台 | |
JP2015208495A (ja) | 遊技台 | |
JP2017060792A (ja) | 遊技台 | |
JP6402341B2 (ja) | 遊技台 | |
JP6518901B2 (ja) | 遊技台 | |
JP2015208487A (ja) | 遊技台 | |
JP2018108471A (ja) | 遊技台 | |
JP6606690B2 (ja) | 遊技台 | |
JP2017047172A (ja) | 遊技台 | |
JP2016179338A (ja) | 遊技台 | |
JP6249458B2 (ja) | 遊技台 | |
JP2015073535A (ja) | 遊技台 | |
JP2015208496A (ja) | 遊技台 | |
JP2016221333A (ja) | 遊技台 | |
JP6402340B2 (ja) | 遊技台 | |
JP6402339B2 (ja) | 遊技台 | |
JP2017060794A (ja) | 遊技台 | |
JP2016179340A (ja) | 遊技台 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20150911 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160801 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20160729 |
|
A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20160804 |
|
A975 | Report on accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A971005 Effective date: 20160926 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20161004 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20161101 |
|
A975 | Report on accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A971005 Effective date: 20170131 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20170207 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20170223 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20170509 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20170519 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20170530 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20170808 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20170824 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20171031 |